Literature DB >> 25101858

CD44 acts through RhoA to regulate YAP signaling.

Yuchen Zhang1, Hongwei Xia1, Xiaojun Ge1, Qingjuan Chen1, Dandan Yuan1, Qi Chen1, Weibing Leng1, Liang Chen1, Qiulin Tang1, Feng Bi2.   

Abstract

The Hippo pathway plays an important role in both physical and pathogenesis processes. As crucial downstream effectors of Hippo pathway, YAP is inhibited by Lats1/2 through phosphorylation. However, upstream signals that regulate the Hippo pathway have been still poorly understood. Here, we found that knockdown of CD44 reduced YAP expression and nuclear localization, but nearly had no effect on its upstream effectors, Mst1 and Lats1. Downregulated CD44 expression also significantly decreased the expression of YAP downstream effectors CTGF, Cyr61 and EDN1 at mRNA level. Our next study showed that knockdown of CD44 inhibited RhoA expression, which was consistent with RhoA knockdown mediated YAP downregulation. Furthermore, we demonstrated that over expression of the constitutively active RhoA (RhoA-V14) could block the YAP expression decrease mediated by CD44 knockdown. Moreover, downregulation of CD44 significantly promoted cell apoptosis and inhibited cell proliferation, cell cycle progression and migration, which were consistent with the effects of RNAi-mediated YAP knockdown in both A549 and HepG2 cells. Overall, data are presented showing that CD44 could act through RhoA signaling to regulate YAP expression and this study also provide new insights into the regulatory mechanisms of the Hippo-YAP pathway.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD44; Hippo; RhoA; YAP

Mesh:

Substances:

Year:  2014        PMID: 25101858     DOI: 10.1016/j.cellsig.2014.07.031

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  27 in total

Review 1.  An overview of signaling pathways regulating YAP/TAZ activity.

Authors:  Boon Chin Heng; Xuehui Zhang; Dominique Aubel; Yunyang Bai; Xiaochan Li; Yan Wei; Martin Fussenegger; Xuliang Deng
Journal:  Cell Mol Life Sci       Date:  2020-08-03       Impact factor: 9.261

2.  A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma.

Authors:  Shumei Song; Min Xie; Ailing W Scott; Jiankang Jin; Lang Ma; Xiaochuan Dong; Heath D Skinner; Randy L Johnson; Sheng Ding; Jaffer A Ajani
Journal:  Mol Cancer Ther       Date:  2017-11-22       Impact factor: 6.261

3.  Osteopontin promotes infarct repair.

Authors:  Itai Rotem; Tal Konfino; Tal Caller; Yeshai Schary; Olga Shaihov-Teper; Dahlia Palevski; Nir Lewis; Daria Lendengolts; Nili Naftali-Shani; Jonathan Leor
Journal:  Basic Res Cardiol       Date:  2022-10-14       Impact factor: 12.416

4.  Discovery of surface biomarkers for cell mechanophenotype via an intracellular protein-based enrichment strategy.

Authors:  Megan E Dempsey; Graylen R Chickering; Rafael D González-Cruz; Vera C Fonseca; Eric M Darling
Journal:  Cell Mol Life Sci       Date:  2022-05-27       Impact factor: 9.207

Review 5.  CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells.

Authors:  Margot Zöller
Journal:  Front Immunol       Date:  2015-05-26       Impact factor: 7.561

6.  Cdc42 deficiency induces podocyte apoptosis by inhibiting the Nwasp/stress fibers/YAP pathway.

Authors:  Z Huang; L Zhang; Y Chen; H Zhang; Q Zhang; R Li; J Ma; Z Li; C Yu; Y Lai; T Lin; X Zhao; B Zhang; Z Ye; S Liu; W Wang; X Liang; R Liao; W Shi
Journal:  Cell Death Dis       Date:  2016-03-17       Impact factor: 8.469

7.  Regulation of CD44 expression and focal adhesion by Golgi phosphatidylinositol 4-phosphate in breast cancer.

Authors:  Takeshi Ijuin; Yukiko Takeuchi; Yohei Shimono; Miki Fukumoto; Emi Tokuda; Tadaomi Takenawa
Journal:  Cancer Sci       Date:  2016-06-24       Impact factor: 6.716

8.  RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal.

Authors:  Zongshun Huang; Li Zhang; Yuanhan Chen; Hong Zhang; Chunping Yu; Fangjian Zhou; Zhiling Zhang; Lijuan Jiang; Ruizhao Li; Jianchao Ma; Zhuo Li; Yuxiong Lai; Ting Lin; Xinchen Zhao; Qianmei Zhang; Bin Zhang; Zhiming Ye; Shuangxin Liu; Wenjian Wang; Xinling Liang; Ruyi Liao; Wei Shi
Journal:  BMC Nephrol       Date:  2016-07-07       Impact factor: 2.388

Review 9.  A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas.

Authors:  Michael D Deel; Jenny J Li; Lisa E S Crose; Corinne M Linardic
Journal:  Front Oncol       Date:  2015-09-02       Impact factor: 6.244

10.  Novel Bioluminescent Activatable Reporter for Src Tyrosine Kinase Activity in Living Mice.

Authors:  Weibing Leng; Dezhi Li; Liang Chen; Hongwei Xia; Qiulin Tang; Baoqin Chen; Qiyong Gong; Fabao Gao; Feng Bi
Journal:  Theranostics       Date:  2016-02-24       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.